These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 17291774)

  • 1. D2-like dopamine receptors mediate the response to amphetamine in a mouse model of ADHD.
    Fan X; Hess EJ
    Neurobiol Dis; 2007 Apr; 26(1):201-11. PubMed ID: 17291774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D2 dopamine receptor subtype-mediated hyperactivity and amphetamine responses in a model of ADHD.
    Fan X; Xu M; Hess EJ
    Neurobiol Dis; 2010 Jan; 37(1):228-36. PubMed ID: 19840852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CB1 receptor knockout mice display reduced ethanol-induced conditioned place preference and increased striatal dopamine D2 receptors.
    Houchi H; Babovic D; Pierrefiche O; Ledent C; Daoust M; Naassila M
    Neuropsychopharmacology; 2005 Feb; 30(2):339-49. PubMed ID: 15383833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of postsynaptic sensitivity to dopaminergic agonists induced by neonatal hippocampal lesions.
    Wan RQ; Corbett R
    Neuropsychopharmacology; 1997 Apr; 16(4):259-68. PubMed ID: 9094143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cocaine and amphetamine depress striatal GABAergic synaptic transmission through D2 dopamine receptors.
    Centonze D; Picconi B; Baunez C; Borrelli E; Pisani A; Bernardi G; Calabresi P
    Neuropsychopharmacology; 2002 Feb; 26(2):164-75. PubMed ID: 11790512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
    Moro H; Sato H; Ida I; Oshima A; Sakurai N; Shihara N; Horikawa Y; Mikuni M
    Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of dopamine receptor antagonists on hyperlocomotion induced by cocaine, amphetamine, MK-801 and the dopamine D1 agonist C-APB in mice.
    O'Neill MF; Shaw G
    Psychopharmacology (Berl); 1999 Aug; 145(3):237-50. PubMed ID: 10494572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of dopamine receptor subtypes in the discriminative stimulus effects of amphetamine and cocaine in rats.
    Filip M; Przegaliński E
    Pol J Pharmacol; 1997; 49(1):21-30. PubMed ID: 9431548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of effects of haloperidol administration on amphetamine-stimulated dopamine release in the rat medial prefrontal cortex and dorsal striatum.
    Pehek EA
    J Pharmacol Exp Ther; 1999 Apr; 289(1):14-23. PubMed ID: 10086982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential sensitivity to acute administration of Ritalin, apomorphine, SCH 23390, but not raclopride in mice selectively bred for hyperactive wheel-running behavior.
    Rhodes JS; Garland T
    Psychopharmacology (Berl); 2003 May; 167(3):242-50. PubMed ID: 12669177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitization of amphetamine-induced stereotyped behaviors during the acute response.
    Kuczenski R; Segal DS
    J Pharmacol Exp Ther; 1999 Feb; 288(2):699-709. PubMed ID: 9918578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one affects dopamine-mediated behavior in rodents.
    Khisti RT; Deshpande LS; Chopde CT
    Psychopharmacology (Berl); 2002 May; 161(2):120-8. PubMed ID: 11981591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of D2-like dopamine receptors in the locomotor stimulant effects of cocaine in mice.
    Chausmer AL; Katz JL
    Psychopharmacology (Berl); 2001 Apr; 155(1):69-77. PubMed ID: 11374338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the D(3) dopamine receptor antagonist, U99194A, on brain stimulation and d-amphetamine reward, motor activity, and c-fos expression in ad libitum fed and food-restricted rats.
    Carr KD; Yamamoto N; Omura M; Cabeza de Vaca S; Krahne L
    Psychopharmacology (Berl); 2002 Aug; 163(1):76-84. PubMed ID: 12185403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation by group I mGLU receptor activation and group III mGLU receptor blockade of locomotor responses induced by D1-like and D2-like receptor agonists in the nucleus accumbens.
    Rouillon C; Degoulet M; Chevallier K; Abraini JH; David HN
    Brain Res; 2008 Mar; 1198():44-54. PubMed ID: 18261716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurochemical and behavioral responses to cocaine in adult male rats with neonatal isolation experience.
    Kosten TA; Zhang XY; Kehoe P
    J Pharmacol Exp Ther; 2005 Aug; 314(2):661-7. PubMed ID: 15845857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride.
    Narendran R; Hwang DR; Slifstein M; Talbot PS; Erritzoe D; Huang Y; Cooper TB; Martinez D; Kegeles LS; Abi-Dargham A; Laruelle M
    Synapse; 2004 Jun; 52(3):188-208. PubMed ID: 15065219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute amphetamine down-regulates RGS4 mRNA and protein expression in rat forebrain: distinct roles of D1 and D2 dopamine receptors.
    Schwendt M; Gold SJ; McGinty JF
    J Neurochem; 2006 Mar; 96(6):1606-15. PubMed ID: 16539683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of drug-induced catalepsy based on dopamine D1, D2, and muscarinic acetylcholine receptor occupancies.
    Haraguchi K; Ito K; Kotaki H; Sawada Y; Iga T
    Drug Metab Dispos; 1997 Jun; 25(6):675-84. PubMed ID: 9193868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of medial prefrontal cortex dopamine in age differences in response to amphetamine in rats: locomotor activity after intra-mPFC injections of dopaminergic ligands.
    Mathews IZ; McCormick CM
    Dev Neurobiol; 2012 Nov; 72(11):1415-21. PubMed ID: 22081646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.